Please login to the form below
Scientific Communication
This page shows the latest Scientific Communication news and features for those working in and with pharma, biotech and healthcare.
Random42 wins Queen’s Award for Enterprise
Will celebrate during the royal reception this summer. Random42 Scientific Communication has been recognised for its excellence in international trade, picking up a Queen’s Award for Enterprise last month. ... Random42, who specialises in medical
Latest news
-
The Global Awards 2016 finalists announced
R&R Partners / Faktory. Random42 Scientific Communication. RevHealth. Saatchi &Saatchi Wellness.
-
The changing role of the modern MSL
Medical affairs now serves as a bridge between our clinical, scientific and commercial teams. ... An optimal point to begin measuring the impact of the MSL is during the prelaunch period, ensuring the ongoing alignment of scientific communication from
-
The new paradigm – in beta mode
These online conversations surpass, in terms of credibility and efficacy. The traditional communication tools such as sales reps, scientific congresses, advertisements and KOL s top-down messages… the pyramid is being ... Needless to say, other
-
Activate your evidence
This is driven by a focus on knowledge acquisition rather than behaviour change; and change is not easily achieved through passive communication alone – no matter how persuasive the argument. ... 3. Integrated international to national and local
-
A very favourable verdict
Client verdict. "The Olmetec on Trial format delivered balanced and compelling communication of scientific data for our customers, which has enabled them to facilitate improved access to treatment for patients through ... Comm uniqué Awards 2010.
More from news
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest Intelligence
-
Medical Affairs: centre-stage in scientific engagement strategies
Its legacy as a trusted scientific partner places Medical Affairs at the forefront of data communication with external stakeholders. ... It is the Medical Affairs team that most commonly spearheads the development of scientific communication platforms, a
-
Bombarded with information – the challenge of crowded digital channels
That’s certainly the case in pharma, where the challenge of getting high-cost medicines to patients is as much about effective communication as it is about scientific innovation. ... However, while the principles of communication haven’t shifted, the
-
Is it time for a more integrated and human-centric approach to Medical Affairs leadership?
lead the communication of increasingly complex science and the implementation of trials that yield real-world evidence (RWE) to demonstrate clinical value. ... Activities must deliver scientific communication of the highest quality, fully leveraging data
-
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
their scientific communication practices. ... Some patients are used to accessing the scientific literature and others are accessing those lay summaries that exist.
-
The critical role of science in healthcare communications
The challenges and opportunities of driving the scientific agenda forward. As dynamic advances in science, medicine and technology continue to accelerate, the world of healthcare is becoming increasingly complex. ... Our aim with the Council is to apply
More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest appointments
-
McCann Health France strengthens team with two new hires
Prior to McCann Health France, she served as scientific director at various international health organisations, including the ARC Foundation for Cancer Research and the French National Cancer Institute. ... More recently, she has worked in strategic and
-
MHRA's Dr June Raine to chair new EMA pharmacovigilance committee
scientific judgement and excellent communication by the PRAC.”.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
The dissemination and consumption of medical literature is evolving
Traditionally, new scientific data would be presented at specialist congresses, subsequently published in a peer-reviewed journal and finally referenced in guidelines (if deemed practicing changing).
-
OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member
London, November 28, 2022 - OPEN Health, a leading global provider of scientific communication and market access services helping pharmaceutical companies to unlock the full potential of their clinical and commercial assets, ... OPEN Health unites
-
The value medical communications bring to phase 2/3 of drug development
It's about structuring the story to really connect with those you are trying to reach, and effective phase 2/3 communication is no different; ‘scientific story telling’ in a nutshell. ... What can a med comms agency bring to good phase 2/3
-
Envision Pharma Group and Alucio™ partner to power next-generation scientific exchange for the life science industry
have the ability to assemble, refine, and adapt their scientific content with ease. ... As a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision) that have applicability across many areas of
-
Envision Pharma Group appoints Head of Envision Value & Access
As a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision) that have applicability across many areas of medical affairs and related functional responsibility, Envision provides scientific
More from PMHub
Approximately 16 fully matching, plus 53 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- PMGroup announces launch of new recruitment platform PharmaRole
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- BioNTech reveals plans to spend about €1bn more on research and development this year
- AstraZeneca’s mild combination asthma reliever approved in UK
- Virtual Patient Engagement Program: A Customer Story
- Putting Skin in the Game at AAD 2023
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Inizio appoints Stefanie Christmas as global head of DE&I
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
